Part 4: Around the World Today

Ayurveda · Part 4 of 6

Ayurveda occupies an unusual position on the global map: more fully institutionalized in one country than perhaps any traditional medical system anywhere on earth, and simultaneously diffused outward into a much looser, largely unregulated global wellness market. Both of those things are true at once, and neither tells the whole story on its own.

Tens of millions of people use Ayurvedic medicine every year, and the range of what that use actually looks like is enormous. In one country, it is a full parallel system of medicine with its own government ministry, licensing boards, and public hospitals. In another, it is a supplement aisle at a health-food store. In a third, it has just been written into national health policy for the first time. Understanding that range – not flattening it into a single global picture – is the point of this part.

India

By any measure, India is where Ayurveda is most deeply and formally institutionalized. It is one of the official systems of medicine recognized and administered by the national government’s Ministry of AYUSH – the cabinet-level ministry, established in its current form in 2014, whose creation Part 2 traced through the decades of committee reports and regulatory milestones that preceded it.

That institutionalization is not symbolic. Ayurvedic medicine is taught as a five-and-a-half-year university degree, the Bachelor of Ayurvedic Medicine and Surgery (BAMS), through roughly 500 recognized colleges across the country, both government and private, admission to which runs through a national entrance process. National regulation of that education and licensing now sits with the National Commission for Indian Systems of Medicine, established under 2020 legislation to replace the earlier Central Council of Indian Medicine – the same modernization of professional oversight that conventional Indian medicine underwent around the same period. Hundreds of thousands of registered BAMS-qualified physicians practice today, described in the practitioner landscape set out in Part 3.

Integration with the public health system runs deeper than licensing alone. The National AYUSH Mission, launched in 2014 alongside the ministry itself, funds AYUSH wings within government hospitals and primary health centers, particularly in rural areas, and supports the cultivation of medicinal plants and the development of dedicated Ayurvedic hospitals. For a meaningful share of rural India, an AYUSH practitioner is not an alternative to the public health system – they are part of it, often the most accessible part.

NOT A NICHE ARRANGEMENT

India is the clearest example in the world of a traditional medical system treated as a parallel, state-sanctioned branch of public health rather than a marginal alternative. For any reader weighing Ayurveda’s place in modern healthcare, India is the case study that complicates easy generalizations in either direction – neither a fringe practice nor a substitute for the country’s own growing investment in conventional medicine, but a formally credentialed system running alongside it.

MEASUREAPPROXIMATE SCALE
BAMS collegesRoughly 500, both government and private, teaching the standardized national curriculum
Registered practitionersCommonly cited in the several hundred thousands, making it one of the largest formally credentialed traditional-medicine workforces in the world
AYUSH hospitals and dispensariesSeveral thousand government-run facilities nationwide, concentrated in but not limited to rural primary care
Domestic industryA multi-billion-dollar manufacturing and retail sector spanning classical formulations, branded over-the-counter products, and cosmetics

That last row is worth pausing on, because it sits behind much of what Part 5 discusses. A formally regulated medical degree and a formally regulated manufacturing sector are two different achievements, and India has pursued both: Ayurvedic, Siddha, and Unani pharmaceutical manufacturing is governed under its own schedule of the country’s Drugs and Cosmetics Act, with Good Manufacturing Practice requirements that licensed Indian manufacturers are expected to meet. That regulatory structure exists and is real. Whether it is consistently enforced across every manufacturer, and what happens to products once they leave India’s borders and enter far less regulated markets abroad, are separate questions – and they are exactly the questions Part 5 takes up in detail.

The Subcontinent and Beyond

Ayurveda’s institutional presence extends, in varying degrees, to India’s neighbors. Sri Lanka maintains its own Ayurveda Act, a dedicated Ministry-level department, government Ayurvedic hospitals, and a state university offering degree-level training – a smaller-scale version of India’s model with real historical roots of its own, distinct from a simple import. Nepal similarly recognizes Ayurveda within its national health framework, with government colleges and a dedicated department, reflecting the shared cultural and religious history across the region rather than a one-directional export from India.

Bangladesh and several other South and Southeast Asian countries maintain smaller-scale registration and training systems for Ayurvedic and related traditional practitioners, typically with less centralized infrastructure than India’s but with a similar underlying logic: formal state recognition of a medical tradition understood as indigenous to the region, not foreign to it.

Beyond South Asia itself, large communities of Indian origin – in Mauritius, Fiji, Trinidad and Tobago, South Africa, and across the Gulf states – have carried Ayurvedic practice with them for generations, often maintained informally through community practitioners and family tradition rather than through the kind of formal licensing seen in India. Mauritius is a partial exception: with a majority-Indian-origin population, it has developed its own government-supported Ayurvedic hospital and training infrastructure, closer in spirit to the subcontinental model than to the diaspora pattern seen elsewhere.

Diaspora and the Global Wellness Market

Outside South Asia, Ayurveda’s presence looks entirely different – less a parallel medical system than a wellness and lifestyle category, carried first by the Indian diaspora and later absorbed into the broader global interest in yoga, meditation, and integrative health that grew rapidly from the late 20th century onward.

A specific and traceable moment accelerated that shift: the popularization of Ayurvedic concepts in the United States during the 1990s, most visibly through physician-authors such as Deepak Chopra, who introduced dosha theory and constitutional wellness to a mainstream Western audience largely unfamiliar with it. What followed was less a medical adoption than a cultural and commercial one – Ayurvedic vocabulary and a handful of its practices (abhyanga oil massage, shirodhara, dosha-based skincare) became fixtures of the global spa and wellness industry, offered in luxury hotels and day spas with little connection to the diagnostic and clinical tradition described in Parts 1 through 3. Kerala itself has built a substantial wellness-tourism industry around this same appeal, with state tourism boards actively marketing certified panchakarma retreats to international visitors – a curious loop in which India’s most clinically serious regional tradition and its most commercially packaged export sit only a few miles apart, sometimes in the same building.

This is worth naming plainly rather than treating as an embarrassment: a hotel spa offering a scented oil massage under the name “Ayurvedic” and a BAMS physician running a supervised panchakarma protocol for a diagnosed condition are doing entirely different things, and the wellness industry’s use of the word has, if anything, made it harder for someone encountering Ayurveda for the first time to tell which one they’re being offered.

FULLY INSTITUTIONALIZED

India, and to a meaningful degree Sri Lanka and Nepal: a government-recognized medical degree, national licensing, public hospitals, and integration into the national health system.

EMERGING REGULATION

Parts of the European Union, Brazil, and several Gulf states: herbal products regulated for safety and quality, practitioner registration beginning to develop, but no independent medical licensing track.

WELLNESS-MARKET ONLY

Most of the United States, the United Kingdom, and much of Western Europe: available largely as dietary supplements and unlicensed wellness services, with no government-recognized practitioner credential.

This gradient matters practically as well as descriptively, because it maps almost exactly onto the practitioner-training table in Part 3. A patient in Kerala consulting a BAMS-qualified physician and a customer in a North American health-food store buying an ashwagandha supplement are both, in some sense, “using Ayurveda” – but they are engaging with entirely different levels of oversight, training, and accountability, and it is worth knowing which one you are actually dealing with.

A Regulatory Snapshot

COUNTRY / REGIONREGULATORY STATUS
IndiaFull medical licensing track (BAMS), national regulator, public hospital integration, government research funding
Sri LankaDedicated Ayurveda Act, government hospitals, university-level training
NepalRecognized within the national health framework, government colleges
BrazilAyurveda added in 2017 to the national list of complementary practices offered through the public health system (SUS), alongside homeopathy and others discussed in the homeopathy series
European UnionHerbal products regulated for safety and manufacturing quality under EU traditional-herbal-medicinal-product rules; practitioner licensing varies by member state and is generally absent
United Arab EmiratesThe Dubai Health Authority and other Gulf regulators have begun licensing frameworks for complementary and traditional practitioners, including Ayurveda, on a jurisdiction-by-jurisdiction basis
United StatesHerbal products regulated as dietary supplements, not drugs; no federal medical licensing for Ayurvedic practice; a small number of states recognize limited scopes of practice
United KingdomUnregulated as a profession; practitioners may voluntarily register with bodies such as the Ayurvedic Practitioners Association, but this is not government licensing
AustraliaNo federal government registration; oversight is association-based and voluntary, similar to the UK

The same word – Ayurveda – describes a licensed medical degree in one country and an unregulated wellness certificate in another. The word alone tells you almost nothing about which one you’re getting.

Integration, With Caveats

The World Health Organization has taken traditional medicine seriously as a matter of global health policy for decades, but its position is more balanced than either enthusiasts or skeptics sometimes present it. The WHO’s Traditional Medicine Strategy has consistently pushed for two things simultaneously: greater integration of traditional systems like Ayurveda into national health infrastructure, particularly in countries where they already serve as a primary source of care for large populations, and stronger regulation, safety monitoring, and evidence generation for exactly those systems. In 2022, the WHO inaugurated its Global Centre for Traditional Medicine in Jamnagar, India – a significant institutional statement about where the organization sees this field heading, and a notable vote of confidence in India’s research and regulatory infrastructure specifically.

INTEGRATION IS NOT THE SAME AS ENDORSEMENT OF EVERY CLAIM

It is worth being precise about what WHO backing actually means here. Support for integrating traditional medicine into health systems, and for investing in its research infrastructure, is not the same as a finding that any specific Ayurvedic remedy is effective for any specific condition. The WHO’s own materials are explicit that traditional medicine’s expanded role should come with expanded quality control, safety monitoring, and evidence standards – including the contamination and quality-control issues discussed in Part 5.

Ayurveda in Western Research Institutions

Alongside the wellness-market diffusion described above, a smaller and more academically serious current has also carried Ayurveda into Western research institutions – distinct from both the spa industry and from India’s own regulatory system, and worth naming separately.

In the United States, the National Center for Complementary and Integrative Health, part of the National Institutes of Health, has funded research into individual Ayurvedic herbs and formulations for several decades, including the trials on turmeric, ashwagandha, and related compounds discussed in Part 3. That funding reflects a research question, not an official government endorsement of Ayurvedic theory – the NCCIH’s own public materials are consistently clear that evidence for most Ayurvedic approaches remains limited and that many claims require further study – but it does mean that a meaningful share of the herbal research underpinning this series was conducted or funded by mainstream biomedical institutions rather than by advocates alone.

A number of American academic medical centers have also built integrative-medicine programs or centers that incorporate Ayurvedic concepts and practitioners alongside conventional care, typically as part of a broader complementary-medicine offering rather than a dedicated Ayurveda department – echoing the adjunctive, oncology-support model described in Part 3. This is a genuinely different institutional pathway from India’s medical-degree model, smaller in scale and narrower in scope, but it represents a distinct third category worth distinguishing from both formal Indian licensure and unregulated wellness marketing: cautious, incremental engagement from within mainstream Western medical research itself.

Institutionalized at Home, Diffuse Abroad

What the global picture shows, then, is a genuine divergence – not between popularity and policy, as with homeopathy’s story in the West, but between depth of institutionalization in Ayurveda’s country of origin and the much shallower, more market-driven presence it has everywhere else. India has spent more than seventy years deliberately building the regulatory, educational, and research infrastructure this series has described. Most of the rest of the world has not, and largely encounters Ayurveda instead through the diaspora, the wellness industry, and an expanding shelf of supplements.

For a reader outside India specifically, that divergence has a direct practical consequence, and it is worth stating before moving on: the credibility signals you would normally rely on – a medical degree, a licensing board, a regulated pharmacy – mostly don’t apply outside the subcontinent, at least not yet, and in most Western markets it is up to the individual consumer to tell a serious practitioner from a marketing exercise. That is not a reason to dismiss what Ayurveda offers. It is a reason to look more closely at exactly who and what you are dealing with – which is precisely where the next two parts go.

That divergence is the honest headline for anyone reading this section, and it sets up the two parts that remain. Part 5 turns to the practical consequences of that gap in oversight – the real safety issues worth knowing, and the wide range of competency a reader is likely to encounter depending on exactly where in this global picture they happen to be looking. Part 6 turns to the practical question of how to navigate that range wisely, wherever you are.